tiprankstipranks
Replimune Group Inc (REPL)
NASDAQ:REPL
Want to see REPL full AI Analyst Report?

Compare Replimune Group (REPL) vs. Competitors

592 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Replimune Group
$15.80
$1.25B
-4.10
114.98%
8 Buy
0 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$3.37
$729.96M
-7.31
57.42%
4 Buy
0 Hold
0 Sell
Strong Buy
Immatics
$9.43
$1.31B
-4.76
48.48%
5 Buy
0 Hold
0 Sell
Strong Buy
Lyell Immunopharma
$15.49
$298.96M
-0.75
-10.08%
4 Buy
0 Hold
1 Sell
Moderate Buy
Candel Therapeutics
$13.28
$866.96M
-7.48
114.55%
5 Buy
1 Hold
0 Sell
Strong Buy
Artiva Biotherapeutics, Inc.
$11.77
$509.44M
-3.09
284.21%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
REPL
Replimune Group
12.92
7.19
125.48%
CTMX
CytomX Therapeutics
3.29
1.29
64.50%
IMTX
Immatics
8.79
2.97
51.03%
LYEL
Lyell Immunopharma
11.96
-0.86
-6.71%
CADL
Candel Therapeutics
10.55
5.76
120.15%
ARTV
Artiva Biotherapeutics, Inc.
10.22
7.67
300.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts